Jun 07, 2021 09:36 PM IST
The new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline, only slowing it in one study. The drug is given as an infusion every four weeks.
- Apr 13, 2021 04:56 PM IST
Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.
- May 10, 2017 12:28 PM IST
Gottlieb, a physician and former deputy FDA commissioner during the George W. Bush administration, is seen as competent and knowledgeable. But critics worry about his ties to the pharmaceutical industry.
- Mar 27, 2017 01:05 PM IST
Tagrisso is designed to help cancer patients with certain genetic mutations that are very common in China and the regulatory green light boosts the British drugmaker's prospects in a key therapy area.
- Mar 21, 2017 05:10 PM IST
The US drug regulator off late, has been a cause of headaches for many domestic pharmaceutical companies. Today, shares of Divis Laboratories tanked 20 percent after an import alert was issued its on Vizag unit. The Dr Reddy's Laboratories shares also hit a 52-week low after the company's Duvvada plant received 13 observations which included repeats from a November, 2015 warning letter.
- Mar 15, 2017 12:44 PM IST
The drug firm received establishment inspection report (EIR) from the US Food and Drug Administration on closure of inspection of its Ankleshwar plant in Gujarat.
- Mar 10, 2017 02:48 PM IST
The US drug regulator had inspected its Baroda unit between March 6 and 10 and issued no Form 483s for the same.
- Jan 19, 2017 12:33 PM IST
The US drug regulator gave a tentative nod for the company's Olmesartan Medoxomil tablets, which is used to treat blood pressure.
- Jul 08, 2016 09:11 AM IST
Of the total 18 observations, 9 from July 2015 and another 9 from March 2016 inspection, the former ones relating to equipment and warehousing have been closed. Nine observations are still outstanding for the company.
- Jul 05, 2016 10:13 AM IST
In an interview to CNBC-TV18, Sanjiv Bhasin of IIFL shared his reading and outlook on the market.
- Jun 27, 2016 10:08 AM IST
This is depite the fact that exports revival in its US and institutional businesses seems distant as the US- Food and Drug Administration (FDA) regulatory issues are likely to remain unresolved in the next two years.
- Jun 10, 2016 10:04 PM IST
The Lupin Pharmaceuticals duo MD Nilesh Gupta and CEO Vinita Gupta say current business conditions only permit revenue visibility of USD 3.5 billion, although their aspiration is to hit USD 5 billion soon. They are among the 50 contenders vying for the World Entrepreneur Award currently being hosted by E&Y at Monte Carlo.
- Jun 01, 2016 10:53 AM IST
Sameer Baisiwala, pharmaceutical and property analyst at Morgan Stanley, feels pharmaceuticals space is a good bet given the recent EIRs issued to domestic pharma companies by the regulator.
- May 24, 2016 12:42 PM IST
Of the total food samples inspected last year, 105 were found to be sub-standard and 30 unfit for human consumption.
- May 05, 2016 08:47 PM IST
Malvinder and Shivinder Singh had sold their stake in Ranbaxy Laboratories to Daiichi way back in 2008, following which Daiichi-led Ranbaxy was forced to pay the US Department of Justice a sum of USD 500 million over non-compliance with US Food and Drug Administration's testing norms.
- Apr 04, 2016 03:36 PM IST
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has received 510(K) clearance from the U.S. Food and Drug ...
- Mar 21, 2016 11:18 AM IST
Bedaquiline, known as the 'miracle drug' is the first TB drug to be approved by Food and Drug Administration (FDA) in over 40 years. The drug will be made available in six public hospitals in Delhi, Mumbai, Chennai, Guwahati and Ahmedabad.
- Feb 02, 2016 09:57 AM IST
The company's subsidiary has received final approval for Imatinib Mesylate from Food and Drug Administration (FDA) in December 2015.
- Feb 01, 2016 03:43 PM IST
Prabhat Awasthi, head of India equities, Nomura, says Bank of Japan's move to go into negative interest rate zone was more of a rate signal and not a liquidity tool for markets
- Jan 18, 2016 01:04 PM IST
Abhishek Sharma, Pharma Analyst at IIFL recommends buying Glenmark Pharma and likes Lupin and Dr Reddy's Labs.
- Dec 28, 2015 04:21 PM IST
The company has received received the final approval from the United States Food and Drug Administration (FDA) to market Fyavolv tablets, Lupin today said in a statement. "Lupin's US subsidiary, Lupin Pharmaceuticals Inc shall commence promoting the product in the US shortly," it added.
- Dec 22, 2015 02:15 PM IST
Pandorum Technologies Pvt. Ltd., the Bangalore-based biotechnology startup working on tissue engineering, announced today that it has developed ...
- Nov 30, 2015 09:22 AM IST
Reiterating that its MAGGI Pazzta is 100 percent safe, Nestle India said that Lucknow-based National Foods Analysis Laboratory and its reports can not be relied upon.
- Nov 28, 2015 02:06 PM IST
Pazzta samples were collected from Nestle distributor - Sriji Traders at Mau on June 10 and were sent to a Lucknow-based government laboratory.
- Oct 14, 2015 08:32 PM IST
The product is a generic version of Forest Laboratories' Namenda tablets in the same strengths, it added.